Independent business intelligence for the life sciences sector
EXPERTISE
Vaccine development, technology & markets   Oncology   Regenerative medicine technology & markets
VACCINES
ONCOLOGY
REGENERATIVE MEDICINE
Example projects undertaken by Beremans in vaccines and related fields include the following:
  • Travel vaccines – products, technologies, clinical need
  • Influence of traveller behaviour on vaccine uptake
  • Physician attitudes to existing and proposed travel vaccines
  • Respiratory pathogen vaccines
  • Enteric pathogen vaccines
  • Vaccine stabilisation technologies
  • Uptake of private and public vaccines in developed and developing world markets
  • Cancer vaccines
  • Small molecule antibiotic therapy
  • Biological antibiotic therapy
  • Pathogen reduction technologies for blood products
  • Anti-inflammatory products and technologies
  • Dengue vaccine market landscape and revenue projections
  • Malaria vaccine market landscape and revenue projections
  • Immunotherapy market landscape and future commercial opportunities
  • Monoclonal antibody therapeutics
Close
Beremans has significant expertise in the vaccines field, and in related areas such as immunotherapy, antibiotics and infection control. Assignments include competition analyses (products, technologies, and companies); qualitative and quantitative analysis of markets by product and country, including revenue projections; and identification of M&A opportunities. Some previous Beremans projects are listed here.
Example projects undertaken by Beremans personnel in oncology-related fields include the following:
  • Oncology applications of novel nanotechnology platform
  • Application of RNAi in cancer treatments / research
  • Gene therapy for cancer
  • Brachytherapy technology
  • Recombinant toxin for cancer applications
  • Clinical trials of cancer therapies
  • Regulatory affairs
  • Drug-related cardiotoxicity
  • Monoclonal antibody therapeutics
  • Technology for cancer biomarker identification and exploitation
  • Pre-launch market research for oncology drug
  • Product positioning material for new oncology drug
  • Environmental scans for new oncology drugs
Close
The field of oncology is a key area of strength for Beremans. Projects have included assessment of the competitive positioning of new treatments. Assignments are facilitated by access to a network of practising oncologists and other key opinion leaders in the field. Representative Beremans experience in the field is given here.
Example projects undertaken by Beremans personnel in fields related to regenerative medicine include the following:
  • Neural stem cell technology
  • Dermal stem cell technology
  • Translational research programme for dermal stem cell technology
  • Stem cell applications in drug discovery
  • Stem cell applications in wound care
  • Stem cell applications in bone repair
  • Stem cell applications in cartilage repair
  • Stem cell applications in stroke rehabilitation
  • Stem cell applications in metabolic disease
  • Orthopaedic implant technologies
  • Osseointegration technologies
  • Prosthesis products and technologies
  • Orthosis products and technologies
  • Protein misfolding diseases and therapies
Close
Beremans has undertaken significant work in the field of regenerative medicine, particularly stem cell technologies (Beremans is a member of the East of England Stem Cell Network (EESCN)), and in related areas such as implanted medical devices and protein misfolding diseases. Outlines of projects undertaken in these fields are provided here.
 
Drug discovery technologies
DRUG DISCOVERY
Drug discovery markets
Example projects undertaken by Beremans personnel in fields related to drug discovery technology include the following:
  • development of automated combinatorial chemistry systems for drug discovery
  • development of assay technology for high throughput screening in drug discovery
  • development of liquid handling technology for high throughput screening in drug discovery
  • development of laser-based scanning systems for high throughput screening in drug discovery
  • assessment of stem cell systems for drug discovery applications
  • assessment of protein array systems for high-throughput screening systems
  • technology for cancer biomarker identification and exploitation
Close
Beremans’ background in drug discovery technology includes the development and commercialisation of systems for high-throughput, automated chemical library synthesis, drug screening, miniaturised liquid handling, assays, and nanotechnology.